DISCOVER study
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
(Redirected from DIagnostic and Severity markers of COVID-19 to Enable Rapid triage)
 | This article is a stub. |
The DISCOVER project is the DIagnostic and Severity markers of COVID-19 to Enable Rapid triage project, which investigates the long-term effects of COVID-19.[1][2]
Talks and interviews[edit | edit source]
- David Arnold on the DISCOVER COVID-19 project - YouTube
- Aug 2020, Coronavirus patients still suffering from complications three months later, study finds - The Independent
Funding[edit | edit source]
Results[edit | edit source]
- Aug 14, 2020 (pre-print), Patient outcomes after hospitalisation with COVID-19 and implications for follow-up; results from a prospective UK cohort[1] - (Full text) - from the DISCOVER project
Criticism[edit | edit source]
Investigators[edit | edit source]
- David T. Arnold, principal Investigator[1]
See also[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
- ↑ 1.0 1.1 1.2 Arnold, David T.; Hamilton, Fergus W.; Milne, Alice; Morley, Anna; Viner, Jason; Attwood, Marie; Noel, Alan; Gunning, Samuel; Hatrick, Jessica (August 14, 2020). "Patient outcomes after hospitalisation with COVID-19 and implications for follow-up; results from a prospective UK cohort". medRxiv: 2020.08.12.20173526. doi:10.1101/2020.08.12.20173526.
- ↑ "Three quarters of patients report long-term effects of coronavius". myscience.uk. August 24, 2020. Retrieved October 11, 2020.
